Cancer Epidemiology Research In Indonesia Based On Riskesdas

16
CANCER EPIDEMIOLOGY RESEARCH IN I NDONESIA, BASED ON RISKESDAS National Institute Health Research & Development Ministry of Health

description

Cancer Epidemiology Research In Indonesia Based On Riskesdas, National Institute Health Research & Development Ministry Of Health

Transcript of Cancer Epidemiology Research In Indonesia Based On Riskesdas

Page 1: Cancer Epidemiology Research In Indonesia Based On Riskesdas

CANCER EPIDEMIOLOGY RESEARCH IN I NDONESIA, BASED ON

RISKESDAS

National Institute Health Research & Development

Ministry of Health

Page 2: Cancer Epidemiology Research In Indonesia Based On Riskesdas

Data sources

• Riskesdas (Basic National health research) 2007

• Susenas (National social economic survey) 2007

Sample

• 33 provinces in Indonesia

• All ages

• Samples of Riskesdas and Susenas same samples

Page 3: Cancer Epidemiology Research In Indonesia Based On Riskesdas

Riskesdas 2007 vs 2010

Riskesdas 2007 Riskesdas 2010

Household Samples 280 000 70 000

Representation District, prov, national Provice, national

Sample unit BS (census block) BS

Total of PH BS 18000 2800

Total of biomedical BS 971 (cities) 823

Choosing Sample BS Same with BS susenas Core of Population Census 2010

Total households/BS 16 25

Collected Data Complete : behavior, Nutrition, Com dis, Non com dis, disabilities, MCH

Focus on MDG’s health indicators kesehatan and determinants

Biomedical samples complete Malaria & Tb

Page 4: Cancer Epidemiology Research In Indonesia Based On Riskesdas

Notes

• Not elaborating tumor specification

• Not elaborating tumor’s origin

• Positive tumor if based on health worker’s diagnosis

• Not mentioning tumor’s onset

• The rate were in per mil (0/00)

Page 5: Cancer Epidemiology Research In Indonesia Based On Riskesdas

Tumor’s prevalence per Province, RKD 2007 (0/00)

0.0

2.0

4.0

6.0

8.0

10.0

12.0

DI Y

ogy

akar

ta

Jaw

a Te

nga

h

DK

I Jak

arta

Ban

ten

Sula

wes

i Uta

ra

Sum

ater

a B

arat

Jaw

a B

ara

t

Bal

i

Sula

wes

i Sel

atan

Sula

wes

i Ten

gah

Jaw

a Ti

mu

r

Ka

lima

nta

n S

ela

tan

Kep

ula

uan

Ria

u

Kal

iman

tan

Ten

gah

Ben

gku

lu

Lam

pu

ng

Kal

iman

tan

Tim

ur

Pap

ua

Ria

u

Jam

bi

Nu

sa T

engg

ara

Tim

ur

Go

ron

talo

Sum

ate

ra U

tara

Nu

sa T

en

gga

ra B

ara

t

Pap

ua

Bar

at

NA

D

Sula

wes

i Ten

ggar

a

Kal

iman

tan

Bar

at

Sula

wes

i Bar

at

Ban

gka

Be

litu

ng

Sum

ater

a Se

lata

n

Mal

uku

Uta

ra

Mal

uku

1,5

4,3

9,6

Page 6: Cancer Epidemiology Research In Indonesia Based On Riskesdas

0

1

2

3

4

5

6

7

8

9

10

<1 1-4 5-14 15-24 25-34 35-44 45-54 55-64 65-74 75+

Tumor’s prevalence for ages group, RKD 2007 (0/00)

Page 7: Cancer Epidemiology Research In Indonesia Based On Riskesdas

0

1

2

3

4

5

6

Laki-Laki Perempuan

0

1

2

3

4

5

6

Kota Desa

Tumor’s prevalence for Sex & place, RKD 2007 (0/00)

Page 8: Cancer Epidemiology Research In Indonesia Based On Riskesdas

0

1

2

3

4

5

6

7

8

9

Tidak Sekolah

Tidak Tamat SD

Tamat SD Tamat SMP Tamat SMA Tamat PT

Tumor’s prevalence for education, RKD 2007 (0/00)

Page 9: Cancer Epidemiology Research In Indonesia Based On Riskesdas

0

1

2

3

4

5

6

7

8

9

Tumor’s prevalence for occupation, RKD 2007 (0/00)

Page 10: Cancer Epidemiology Research In Indonesia Based On Riskesdas

0

1

2

3

4

5

6

7

Kuintil-1 Kuintil-2 Kuintil-3 Kuintil-4 Kuintil-5

Tumor’s prevalence for Economic status, RKD 2007 (0/00)

Page 11: Cancer Epidemiology Research In Indonesia Based On Riskesdas

STRUKTUR ORGANISASI BADAN PENELITIAN, PENGEMBANGAN KESEHATAN DAN

PENAPISAN TEKNOLOGI KESEHATAN

SEKRETARIATBADAN

PUSAT PENELITIAN DANPENGEMBANGAN

HUMANIORA, KEBIJAKAN KESEHATAN DAN PEMBERDAYAAN

MASYARAKAT

PUSAT PENELITIAN DANPENGEMBANGAN

TEKNOLOGI KESEHATANTERAPAN DAN

EPIDEMIOLOGI KLINIK

PUSAT PENELITIAN DANPENGEMBANGAN

TEKNOLOGI INTERVENSIKESEHATAN MASYARAKAT

PUSAT PENELITIAN DANPENGEMBANGAN

BIOMEDIS DANTEKONOLOGI

DASAR KESEHATAN

BADAN PENELITIAN, PENGEMBANGAN KESEHATAN DAN PENAPISAN TEKNOLOGI

KESEHATAN

Page 12: Cancer Epidemiology Research In Indonesia Based On Riskesdas

Manfaat Jamu/Obat Tradisional Menurut Provinsi

96.66 95.6

83.23

75

80

85

90

95

100

MA

LUT

BA

LI

KA

LSEL

NA

D

IND

ON

ESIA

NTB

KA

LBA

R

MA

LUK

U

KEP

RI

JATI

M

LAM

PU

NG

JAM

BI

SUM

UT

JATE

NG

SUM

SEL

SULB

AR

BA

NTE

N

JAB

AR

KA

LTEN

G

DK

I

BA

BEL DIY

KA

LTIM

RIA

U

BEN

GKU

LU

SULT

ENG

SULT

RA

GO

RO

NTA

LO

PAB

AR

NTT

SULS

EL

SULU

T

PAP

UA

SUM

BA

R

Kemanfaatan : 95,6% merasakan manfaat ( 83,23 – 96,66%)

Page 13: Cancer Epidemiology Research In Indonesia Based On Riskesdas

Merasakan Manfaat Jamu/Obat Tradisional Menurut Karakteristik

84

86

88

90

92

94

96

15

-24

25

-34

35

-44

45

-54

55

-64

65

-74

75+

Laki

laki

Pere

mp

uan

Pe

rko

taan

Per

des

aan

Tid

ak s

eko

lah

Tid

ak t

amat

SD

Tam

at S

D

Tam

at S

MP

Tam

at S

MA

Tam

at P

T

Tid

ak k

erj

a

Seko

lah

TNI/

PO

LRI

Peg

awai

/P

NS

Pela

yan

jasa

/dag

ang

Bu

ruh

/tan

i/n

elay

an

Lain

nya

Ku

inti

l 1

Ku

inti

l 2

Ku

inti

l 3

Ku

inti

l 4

Ku

inti

l 5

Page 14: Cancer Epidemiology Research In Indonesia Based On Riskesdas

6 PROGRAM LITBANGKES

(RENSTRA-RPJMN 2009 – 14)

•KELEMBAGAAN

•PERORANGAN

PROGRAM UNIT UTAMA

(DIT/SUBDIT DLL)

+ VALUE BASED

SASARAN PROGRAM KEMKES

TERCAPAI TANPA MALPRAKTEK

Page 15: Cancer Epidemiology Research In Indonesia Based On Riskesdas

Pindah jabfung lit:

< 45 tahun

Profesor Riset

Page 16: Cancer Epidemiology Research In Indonesia Based On Riskesdas

Conclusion

• The recent cancer epidemiology data of national level submitted by NIHRD

• NIHRD act as an executive agency conducting National Basic Health research in RI periodically

• NIHRD also act as the cooordinator of national research and development by implementing the scheme of ad hoc researcher and collaborating with univeristy and teahing hospital’s researchers, developing master and PhD by research.